Tempur Sealy International is planning to introduce the antimicrobial and antiviral Surface-Guard Technology on select Sealy products beginning in early 2021.
The Environmental Protection Agency-registered antimicrobial technology kills 99 percent of bacteria on mattress surfaces and, in testing, has also shown to be at least 99 percent effective against killing viruses (including the human coronavirus) on textiles within five minutes, according to the company. The company is pursuing antiviral-efficacy claims approval from the U.S. Food & Drug Administration and the EPA. (The product is not currently registered for any public health use in the U.S.)
This technology is designed to add enhanced mattress protection across the Sealy Posturepedic and Sealy Posturepedic Plus mattress collections and will build on the antimicrobial and antiallergen treatment developed and first used by Tempur Sealy more than 10 years ago.
Tempur Sealy also plans to incorporate Surface-Guard Technology into the Tempur-Pedic and Stearns & Foster lines in 2021 in order to make the protection available to more consumers.
“Tempur Sealy is proud to announce our plans to incorporate Surface-Guard Technology antimicrobial and antiviral treatment on Sealy, Tempur-Pedic and Stearns & Foster products as soon as early next year,” said Scott Thompson, Tempur Sealy chairman, CEO and president. “Making Surface-Guard Technology available across our industry-leading portfolio of brands represents the latest in a long line of innovations from Tempur Sealy.”